GABAA receptors in aging and Alzheimer's disease

Journal of Neurochemistry

Volumn 103, Issue 4, 2007, Pages 1285-1292

  Rissman, Robert A ^a   De Blas, Angel L ^b   Armstrong, David M ^c,d  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Age; Aging; Alzheimer's disease; Benzodiazepine receptor; GABA; GABAA receptor; Inhibitory neurotransmission; Receptor subunits

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID C RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBON 11; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIAZEPAM; FLUMAZENIL; MIDAZOLAM; MUSCIMOL; ZOLPIDEM;

AGING; ALZHEIMER DISEASE; BRAIN; BRAIN DISEASE; DRUG RECEPTOR BINDING; HUMAN; NERVE DEGENERATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

AGING; ALZHEIMER DISEASE; ANIMALS; GAMMA-AMINOBUTYRIC ACID; HUMANS; PROTEIN SUBUNITS; RECEPTORS, GABA-A;

EID: 35449007976     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04832.x     Document Type: Review

References (79)

1. Aronica E., Dickson D. W., Kress Y., Morrison J. H. Zukin R. S. (1998) Non-plaque dystrophic dendrites in the Alzheimer hippocampus: a new pathological structure revealed by glutamate receptor immunocytochemistry. Neuroscience 82, 979 991.
2. Arundine M. Tymianski M. (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657 668.
3. A receptor deduced from mutation-induced rectification. Neuroreport 5, 285 288.
4. Banay-Schwartz M., Lajtha A. Palkovitis M. (1989) Changes with aging in the levels of the amino acids in rat CNS structural elements. I. Glutamate and related amino acids. Neurochem. Res. 14, 555 562.
5. Barnard E. A., Skolnick P., Olsen R. W., Mohler H., Siegart W., Biggio G., Braestrup C., Bateson A. N. Langer S. Z. (1998) International Union of Pharmacology. XV. Subtypes of GABAA receptor: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291 331.
6. Bonnert T. P., McKernan R. M., Farrar S. et al. (1999) θ, a novel γ-aminobutyric acid type A receptor subunit. Proc. Natl Acad. Sci. USA 96, 9891 9896.
7. Carlson M. D., Penny J. B. Jr. Young A. B. (1993) NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex. Neurobiol. Aging 14, 343 352.
8. A receptor subunit composition and function in rat auditory system. Neuroscience 93, 307 312.
9. A receptor changes in Alzheimer's disease. Neurosci. Lett. 82, 246 252.
10. - flux in rat membrane vesicles. Life Sci. 43, 1761 1771.
11. - channel complex. J. Neurosci. 8, 602 614.
12. A receptor-coupled chloride ionophore in rat cerebral cortex. J. Neurochem. 53, 648 651.
13. Farrar S. J., Whiting P. J., Bonnert T. P. McKernan R. M. (1999) Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer. J. Biol. Chem. 274, 10100 10104.
14. A receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359, 154 194.
15. Garcia R. Jaffard R. (1993) A comparative study of age-related changes in inhibitory processes and long-term potentiation in the lateral septum of mice. Brain Res. 620, 229 236.
16. 3H]glutamate binding. J. Neurochem. 48, 543 551.
17. Griffith W. Murchison D. A. (1995) Enhancement of GABA-activated membrane currents in aged Fischer 344 rat basal forebrain neurons. J. Neurosci. 15, 2407 2416.
18. A receptor subunits and gluamic acid decarboxylase in the rat inferior colliculus. J. Neurosci. 14, 7469 7477.
19. A receptor in the rat hippocampus. Neuroscience 74, 341 348.
20. Gutierrez A., Khan Z. U., Miralles C. P. De Blas A. L. (1996b) Altered expression of gamma 2L and gamma 2S GABAA receptor subunits in the aging rat brain. Mol. Brain Res. 35, 91 102.
21. A receptor subunit expression changes in the rat cerebellum and cerebral cortex during aging. Mol. Brain Res. 45, 59 70.
22. 3H-diazepam binding in aged mice. Life Sci. 29, 971 974.
23. A receptors in the human hippocampal formation. J. Neurosci. 8, 1370 1383.
24. A receptors are preserved in the hippocampus of Alzheimer's disease patients. Neuroscience 98, 669 675.
25. Ikonomovic M. D., Sheffield R. Armstrong D. M. (1995) AMPA-selective glutamate receptor subtype immunoreactivity in the aged human hippocampal formation. J. Comp. Neurol. 359, 239 252.
26. Ikonomovic M. D., Mizukami K., Davies P., Hamilton R., Wenthold R. J., Sheffield R. Armstrong D. M. (1999) Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease. Exp. Neurol. 160, 194 204.
27. Iwakiri M., Mizukami K., Ishikawa M. Asada T. (2006) GABA(A) receptor gamma subunits in the hippocampus of the rat after perforant pathway lesion. Neurosci. Lett. 394, 88 91.
28. Jansen K. L. R., Faull R. L. M., Dragunow M. Synek B. L. (1990) Alzheimer's disease: changes in NMDA, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin, and opiod receptors - an autoradiographic study. Neuroscience 39, 613 627.
29. A receptors containing alpha6 subunits. J. Neurosci. 18, 2449 2457.
30. A/benzodiazepine receptors. J. Neurochem. 63, 1466 1476.
31. A/benzodiazepine receptor from rat cerebellum. J. Neurochem. 63, 371 374.
32. Khan Z. U., Gutierrez A. De Blas A. L. (1996) The alpha 1 and alpha 6 subunits can coexist in the same cerebellar GABAA receptor maintaining their individual benzodiazepine-binding specificities. J. Neurochem. 66, 685 691.
33. Komiskey H. L. (1987) Aging: effect on ex-vivo benzodiazepine binding after diazepam injection. Neurochem. Res. 12, 745 749.
34. Komiskey H. L. MacFarlan M. F. (1983) Aging: effect on neuronal and non-neuronal benzodiazepine binding sites. Neurochem. Res. 8, 1135 1141.
35. Kullmann D. M., Ruiz A., Rusakov D. M., Scott R., Semyanov A. Walker M. C. (2005) Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? Prog. Biophys. Mol. Biol. 87, 33 46.
36. Li M. De Blas A. L. (1997) Coexistence of two beta subunit isoforms in the same gamma-aminobutyric acid type A receptor. J. Biol. Chem. 272, 1654 1659.
37. Lowe S. L., Francis P. T., Procter A. W., Palmer A. M., Davison A. N. Bowen D. M. (1988) Gamma-butyric acid concentration in brain tissue at two stages of Alzheimer's disease. Brain 111, 785 799.
38. A receptor channels. Annu. Rev. Neurosci. 17, 569 602.
39. Marczynski T. J. (1995) GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease: pharmacologic profile of the benzodiazepine antagonist, flumazenil. Rev. Neurosci. 6, 221 258.
40. Marczynski T. J. (1998) GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited. Brain Res. Bull. 45, 241 379.
41. Meyer M., Koeppe R. A., Prey K. A., Foster N. L. Kuhl D. E. (1995) Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Arch. Neurol. 52, 314 317.
42. A receptor subunit mRNA levels in Fischer rats. Mol. Brain Res. 14, 71 78.
43. Miralles C. P., Li M., Mehta A. K., Khan Z. U. De Blas A. L. (1999) Immunocytochemical localization of the beta(3) subunit of the gamma-aminobutyric acid(A) receptor in the rat brain. J. Comp. Neurol. 413, 535 548.
44. Aβ2/3 immunoreactivity in the dentate gyrus after perforant pathway lesion. Neuroreport 8, 129 139.
45. A receptor Beta2/3 in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Exp. Neurol. 147, 333 345.
46. A receptor α1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Brain Res. 799, 148 155.
47. Mizukami K., Grayson D. R., Ikonomovic M. D., Sheffield R. Armstrong D. M. (1998b) GABA-A receptor beta 2 and beta 3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology. Brain Res. Mol. Brain Res. 56, 268 272.
48. A receptors. From subunits to diverse functions. Ion Channels 4, 89 113.
49. Moreno J. I., Piva M. A., Miralles C. P. De Blas A. L. (1994) Immunocytochemical localization of the beta 2 subunit of the gamma-aminobutyric acidA receptor in the rat brain. J. Comp. Neurol. 350, 260 271.
50. Mountjoy C. Q., Rossor M. N., Iverson L. L. Roth M. (1984) Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. Brain 107, 507 518.
51. A receptors. FASEB J. 4, 1469 1480.
52. Pedigo N. W., Schoemaker H., Morelli M., McDougal J. N., Malick J. B., Bucks T. F. Yamamura H. I. (1981) Benzodiazepine receptor binding in young, mature, and senescent rat brain and kidney. Neurobiol. Aging 2, 83 88.
53. Pellegrini-Giampietro D. E., Gorter J. A., Bennett M. V. Zukin R. S. (1997) The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20, 464 470.
54. A receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101, 815 850.
55. A receptor research. Synapse 21, 189 274.
56. Reeves P. M. Schweizer M. P. (1983) Aging, diazepam exposure and benzodiazepine receptors in the rat cortex. Brain Res. 270, 376 379.
57. Reinkainen K. J., Paljarvi L., Huuskonen M., Soininen H., Laakso M. Riekinen P. J. (1988) A post-mortem study of the nonadrenergic, serotonergic, and GABAergic neurons in Alzheimer's disease. J. Neurol. Sci. 84, 101 116.
58. A receptor subunits α1, α5, β1, β2 in the hippocampus of patients with Alzheimer's disease neuropathology. Neuroscience 120, 695 704.
59. Rissman R. A., Bennett D. A. Armstrong D. M. (2004) Subregional analysis of GABA(A) receptor subunit mRNAs in the hippocampus of older persons with and without cognitive impairment. J. Chem. Neuroanat. 28, 17 25.
60. a receptor α1 and β2/3 subunits in the non-human primate hippocampus. Brain Res. 1073, 120 130.
61. Rossor M. N., Garrett N. J., Johnson A. L., Mountjoy C. Q., Roth M. Iversen L. L. (1982) A postmortem study of the cholinergic and GABA systems in senile dementia. Brain 105, 313 330.
62. a/benzodiazepine in the rat hippocampus during aging. J. Pharmacol. Exp. Ther. 256, 902 908.
63. A sites benzodiazepine receptor complex in the rat nervous system. J. Neurochem. 58, 485 493.
64. a/benzodiazepine receptor complex. Eur. J. Pharmacol. 267, 123 128.
65. a receptor complex from rat cerebral cortex and hippocampus. J. Neurochem. 64, 867 873.
66. Ruano D. J., Benavides J., Machado A. Vitoria J. (1995) Aging-associated changes in the pharmacological properties of the benzodiazepine (ω) receptor isotypes in the rat hippocampus. Mol. Brain Res. 25, 225 233.
67. Ruano D., Araujo F., Revilla E., Vela J., Bergis O. Vitorica J. (2000) GABA-A and alpha-amino-3-hydroxy-5-methylsoxazole-4-propionate receptors are differentially affected by aging in the rat hippocampus. J. Biol. Chem. 275, 19585 19593.
68. Rudolph U Mohler H. (2006) GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr. Opin. Pharmacol. 6, 18 23.
69. A receptors in neocortex. Mol. Brain Res. 14, 207 212.
70. Steiger J. L. Russek S. J. (2004) GABA-A receptors: building the bridge between subunit mRNAs, their promoters, and cognate transcription factors. Pharmacol. Ther. 101, 259 281.
71. A receptors have α5β3γ2 characteristics. Mol. Pharmacol. 54, 928 933.
72. A receptors in the rat brain. Brain Res. 822, 265 270.
73. Tsang C. C., Speeg K. V. Wilkinson G. R. (1982) Aging and benzodiazepine binding in the rat cerebral cortex. Life Sci. 30, 343 346.
74. A muscarinic, and β adrenoceptors and euron degeneration in the cingulate cortex in Alzheimer's Disease. Mol. Pharmacol. 43, 240 244.
75. A binding in the brains of aged rats and monkeys. Neurobiol. Aging 12, 93 98.
76. Whiting P. J. (2003) GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov. Today 8, 445 450.
77. A receptor subtypes. Int. Rev. Neurobiol. 38, 95 138.
78. A receptor gene family. Ann. N. Y. Acad. Sci. 868, 645 653.
79. A receptor subunit mRNA in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12, 1041 1062.